Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1272 of 10,302 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: PAIN Clear all

Conditions: Pain
Interventions: Standard of Care First, ph Altered first; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 122 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Breast Cancer, Arthralgia
Interventions: Education and exercise intervention, Education and General Exercise; Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: HIV Associated Polyneuropathy
Interventions: Transcutaneous Auricular Vagus Nerve Stimulation (AVNS); Device
Lead sponsor: University of Miami; Other
Eligibility: 50 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions: Cromolyn Sodium, Cetirizine Hydrochloride; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years to 80 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Primary Fibromyalgia
Interventions: TNX-102 SL 2.8mg, Placebo; Drug
Lead sponsor: Tonix Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 17
States / cities: Sacramento, California • Denver, Colorado • Brooksville, Florida + 14 more

Conditions: Chronic Pain
Interventions: Precision or Precision Spectra Spinal Cord Stimulator System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 22 Years and older
Enrollment: 229 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 26
States / cities: Phoenix, Arizona • Carlsbad, California • Redwood City, California + 22 more

Conditions: Point-of-Care Bladder Ultrasound, Urethral Catheter
Interventions: Bladder Ultrasound, Standard of Care; Device · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 8 Years to 18 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Influenza
Interventions: favipiravir, placebo; Drug
Lead sponsor: MDVI, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 1,161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 147
States / cities: Birmingham, Alabama • Huntsville, Alabama • Camp Verde, Arizona + 123 more

Conditions: Pain, Postoperative
Interventions: Intranasal morphine, Placebo, IV morphine; Drug
Lead sponsor: Javelin Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 7
States / cities: Phoenix, Arizona • Bakersfield, California • State College, Pennsylvania + 3 more

Conditions: Articular Cartilage Disorder, Degeneration; Articular Cartilage, Chronic Cartilage Injury, Acute Cartilage Injury, Defect of Articular Cartilage
Interventions: Neocartilage Implant/DeNovo® ET (Engineered Tissue Graft), Microfracture; Biological · Other
Lead sponsor: ISTO Technologies, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 9
States / cities: Los Angeles, California • Santa Monica, California • Chicago, Illinois + 5 more

Conditions: Chronic Inflammation, Chronic Pain, Fatigue, Cognitive Impairment
Interventions: Modified-Release Prednisone, Placebo; Drug
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: Not listed
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Postoperative Pain
Interventions: Q8003 (morphine sulfate and oxycodone hydrochloride), Low dose Q8003 (morphine sulfate and oxycodone hydrochloride), Percocet (oxycodone and acetaminophen); Drug
Lead sponsor: QRxPharma Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 4
States / cities: Birmingham, Alabama • Phoenix, Arizona • Royal Oak, Michigan + 1 more

Conditions: Labor Pain
Interventions: Sterile normal saline 0 mls, 15 mls sterile normal saline; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 12 Years and older · Female only
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Abdominal Pain, Inflammatory Bowel Diseases, Eosinophilic Gastroenteritis, Diarrhea, Hematochezia, Weight Loss
Interventions: Ondansetron; Drug
Lead sponsor: State University of New York - Downstate Medical Center; Other
Eligibility: 2 Years to 20 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Pain, Postoperative, Pain, Chronic
Interventions: Fluoroscopy, Traditional; Device · Procedure
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Hip Osteoarthritis
Interventions: Lumbar plexus block, Quadratus lumborum type 3 block, Ropivacaine injection; Procedure · Drug
Lead sponsor: Sharad Khetarpal; Other
Eligibility: 18 Years to 90 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Fibromyalgia
Interventions: Strength training, Aerobic exercise; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Keratoconus, Unstable, Collagen Crosslinking, Postoperative Pain
Interventions: Dextenza, Prednisolone Acetate; Drug
Lead sponsor: Sight Medical Doctors PLLC; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Babylon, New York

Conditions: Pain
Interventions: Hylenex; Drug
Lead sponsor: Halozyme Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 2
States / cities: San Diego, California

Conditions: Skin to Skin Contact in Cesarean Deliveries
Interventions: skin to skin; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Postsurgical Pain Due to Third Molar Extraction
Interventions: V117957, Ibuprofen, Placebo; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 114 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Opioid-Related Disorders
Interventions: Buprenorphine; Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 25 Years to 55 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Pain
Interventions: Relief Product Placebo Control, Relief Active Product 1, Relief Active Product 2, Relief Active Product 3; Dietary Supplement
Lead sponsor: Radicle Science; Industry
Eligibility: 21 Years to 105 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Del Mar, California

Conditions: Femoracetabular Impingement, Pain, Postoperative
Interventions: Morphine with clonidine, Normal saline; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?

The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer

Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy

Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)

Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude

BULLET: Bladder Ultrasound Limits Length (of Time), Expedites Treatment

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults

Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery

Neocartilage Implant to Treat Cartilage Lesions of the Knee

Gulf War Illness Inflammation Reduction Trial

Pilot Study of the Efficacy and Safety of Q8003 in Patients Who Have Undergone Total Knee Arthroplasty or Total Hip Arthroplasty

Combined Spinal/Epidural (CSE) Saline Duration/Spread

Examining the Effect of Ondansetron on Bowel Prep Success

Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters

Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement

Exercise for Fibromyalgia

Intracanalicular Dexamethasone Insert for Post-Corneal Cross-Linking Inflammation and Pain- The LINK Study

INFUSE Morphine Study

Impact of Skin to Skin Contact on Maternal Satisfaction, Pain Scores, and Narcotic Usage After Cesarean Delivery

An Analgesic Study to of V117957 for the Treatment of Postsurgical Pain Due to Third Molar Extraction

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Radicle Relief 24_RLN: A Study Assessing the Impact of Health and Wellness Products on Pain and Related Health Outcomes.

Intra-articular Morphine and Clonidine Injections for Pain Management in Hip Arthroscopy